Canadian Association of Nurses in Oncology

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1002/pon.5021 Returning to work after cancer: Survivors', caregivers', and employers' perspectives
https://doi.org/10.4103/2347-5625.195885 Global perspectives on cancer health disparities: Impact, utility, and implications for cancer nursing
https://doi.org/10.5737/236880762517381 Health disparities in cancer care: Exploring Canadian, American and international perspectives
https://doi.org/10.1002/pon.4831 Enhancing clinical practice in the management of distress: The Therapeutic Practices for Distress Management (TPDM) project
https://doi.org/10.3390/curroncol31040136 Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement
https://doi.org/10.1016/j.soncn.2024.151588 Cancer Patient Navigation in Canada: Directions From the North
https://doi.org/10.3747/co.26.4833 Never too Old to Learn New Tricks: Surveying Canadian Health Care Professionals about Learning Needs in Caring for Older Adults with Cancer
https://doi.org/10.3917/jepam.105.0023 The Cirque du Soleil:
CANO/ACIO International Symposium: Working in partnership within and beyond our Canadian borders to enhance oncology care.
I'm nursing as fast as I can: how the history of cancer and cancer care informs the future of oncology nursing.
https://doi.org/10.5737/236880762518292 Disparités en matière de santé en cancérologie : exploration de perspectives canadiennes, américaines et internationales
Communicating your research.
Setting the stage for strategic planning- Perspectives of CANO/ACIO Members 2021.
Future ready: Strengthening oncology nursing leadership in the context of professional oncology nursing organizations.
https://doi.org/10.1200/jco.2016.34.15_suppl.1088 Phase (Ph) 1 study of oral seviteronel (VT-464), a dual CYP17-Lyase (L) inhibitor and androgen receptor (AR) antagonist, in patients (pts) with advanced AR+ triple negative (TNBC) or estrogen receptor (ER)+ breast cancer (BC).
https://doi.org/10.20944/preprints202402.0773.v1 Access to Oncology Medicines in Canada: Consensus Forum for Recommendations for Improvement
https://doi.org/10.7748/cnp2012.07.11.6.9.p8878 Living beyond cancer resource
[Creutzfeldt-Jacob disease and other prion diseases. Implications for nurses].
Report from the Director-at-Large-- Professional Practice.
Report from the Director-at-Large-- Education.
Oncology nursing: a calling, a career or both?
Developing a national strategy for chemotherapy administration for oncology nurses in Canada.
Communiquer ses résultats de recherches.
International partnerships in cancer care: Cultural bridging for oncology nurses.
https://doi.org/10.3917/eres.cheml.2023.01.0079 L’engagement dans l’espace de la rencontre transférentielle
https://doi.org/10.62606/rmmao00167 Caractéristiques épidémio-cliniques des cancers des voies aéro- digestives supérieures au Service Oncologie du CHUA/JRA de 2008 à 2012
Cancer and social justice: What's advocacy got to do with it?
https://doi.org/10.1007/s00520-025-09880-1 Five prerequisites to achieving excellence in supportive cancer care by 2030: oncology nursing in the driver’s seat
Past, present and future: From vision to action: A strategic roadmap for empowering nurses.
https://doi.org/10.5737/2368807636166 Translating evidence into practice: Developing Canada’s first position statement on genomics-informed oncology nursing
https://doi.org/10.5737/2368807636173 Traduire la recherche en pratique : premier énoncé de position du Canada sur les soins infirmiers en oncologie basés sur la génomique
Forging a bold new path: 2026-2030 Strategic Plan Excel.
https://doi.org/10.5281/zenodo.22924115 Protocol 1: Pediatric Rare Disease Clinical Trials Inventory: A Living Scoping Review Protocol
https://doi.org/10.5281/zenodo.23025898 Protocol 1: Pediatric Rare Disease Clinical Trials Inventory: A Living Scoping Review Protocol